Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000795606 | SCV000935074 | uncertain significance | Arrhythmogenic right ventricular dysplasia 11 | 2021-08-28 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine with serine at codon 716 of the DSC2 protein (p.Cys716Ser). The cysteine residue is highly conserved and there is a moderate physicochemical difference between cysteine and serine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with DSC2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002426866 | SCV002730405 | uncertain significance | Cardiovascular phenotype | 2021-05-20 | criteria provided, single submitter | clinical testing | The p.C716S variant (also known as c.2147G>C), located in coding exon 14 of the DSC2 gene, results from a G to C substitution at nucleotide position 2147. The cysteine at codon 716 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV003996599 | SCV004818647 | uncertain significance | Familial isolated arrhythmogenic right ventricular dysplasia | 2023-03-28 | criteria provided, single submitter | clinical testing |